William John Sibold - Sep 9, 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
President and CEO, Director
Signature
/s/ Mardi Dier**
Stock symbol
MDGL
Transactions as of
Sep 9, 2024
Transactions value $
-$1,551,490
Form type
4
Date filed
9/11/2024, 09:51 PM
Previous filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Sale -$1.55M -6.36K -10.22% $243.83 55.9K Sep 9, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Remarks:

** As attorney-in-fact for Reporting Person